Clinical trial

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

NCT04030546

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-06-01

PhasePHASE3

Study timeline

Study start (actual)2019-06-01Date precision: day

Registry last updated2019-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Patients With Cancerunresolved

Interventions

IvabradineDRUG · verified · RxNorm: ivabradine

Sponsors & collaborators

Vilnius Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04030546 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.